AU2021453749A1 — Crystalline forms of 3-{4-[(2r)-2-aminopropoxy]phenyl}-n-[(1r)- 1-(3-fluorophenyl) ethyl]imidazo[1,2-b]pyridazin-6-amine and salts thereof
Assigned to Nuvation Bio Inc · Expires 2023-12-21 · 2y expired
What this patent protects
This disclosure relates to crystalline forms of 3- {4- [ (2R) -2-aminopropoxy] phenyl} -N- [ (1R) -1- (3-fluorophenyl) ethyl] imidazo [1, 2-b] pyridazin-6-amine and its salts, as well as methods of preparing and using such crystalline forms.
USPTO Abstract
This disclosure relates to crystalline forms of 3- {4- [ (2R) -2-aminopropoxy] phenyl} -N- [ (1R) -1- (3-fluorophenyl) ethyl] imidazo [1, 2-b] pyridazin-6-amine and its salts, as well as methods of preparing and using such crystalline forms.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.